- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2023 1

Journal Article 1

1 Results

Refine Results

All Collections

Refine Results:

All Collections

Trends in Lipid Lowering Prescriptions: Increasing Use of Guideline Concordant Pharmacotherapies — U.S., 2017–2022

CITE Title : Trends in Lipid Lowering Prescriptions: Increasing Use of Guideline Concordant Pharmacotherapies — U.S., 2017–2022 Personal Author(s) : Sekkarie, Ahlia;Park, Soyoun;Therrien, Nicole L.;Jackson, Sandra L.;Woodruff, Rebecca C.;Attipoe-Dorcoo, Sharon;Yang, Peter K.;Sperling, Laurence;Loustalot, Fleetwood;Thompson-Paul, Angela M.; Published Date : 4 2023;4-2023; Source : Am J Prev Med. 64(4):561-566 URL : https://stacks.cdc.gov/view/cdc/126185 Sekkarie, Ahlia et al. (2023). Trends in Lipid Lowering Prescriptions: Increasing Use of Guideline Concordant Pharmacotherapies — U.S., 2017–2022. 64(4). Sekkarie, Ahlia et al. "Trends in Lipid Lowering Prescriptions: Increasing Use of Guideline Concordant Pharmacotherapies — U.S., 2017–2022" 64, no. 4 (2023) Sekkarie, Ahlia et al. "Trends in Lipid Lowering Prescriptions: Increasing Use of Guideline Concordant Pharmacotherapies — U.S., 2017–2022" vol. 64, no. 4, 2023 Export RIS Citation Information.

:

Sekkarie, Ahlia ;

Park, Soyoun

4 2023 | Am J Prev Med. 64(4):561-566

:

Introduction:Almost one-third of U.S. adults have elevated low-density lipid cholesterol (LDL-C) increasing their risk of atherosclerotic cardiovascul...

To see more results, try removing search filters or changing the search terms